Skip to main content
OpenTrials

Clinical trial condition

Chromosome Aberrations

Explore clinical trials studying Chromosome Aberrations. Study availability and eligibility vary by location and protocol.

100 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Chromosome Aberrations trial results

Completed

Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL)

NCT01724879

Conditions
Chromosome Aberrations, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Robert Bosch Krankenhaus Stuttgart, Baden-Wurttemberg, Germany
  • Klinikum der Universität Regensburg Regensburg, Bavaria, Germany
  • University Hospital of Frankfurt, Medical Dept. II Frankfurt am Main, Hesse, Germany
  • Medizinische Hochschule Hannover Hanover, Lower Saxony, Germany
View all 22 locations
View Trial Details
Completed

Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies

NCT01052688

Conditions
Abnormalities, Multiple, Aneuploidy, Chromosome Aberrations, +13 more
Locations
  • Perinatal Care Associates Phoenix, Arizona, United States
  • St. Joseph's Hospital and medical Center Phoenix, Arizona, United States
  • Sharp Grossmount San Diego, California, United States
  • IGO San Diego, California, United States
View Trial Details
Completed

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

NCT00171249

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +23 more
Locations
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • New York Presbyterian Hospital New York, United States
  • Oregon Health & Sciences University Portland, Oregon, United States
  • MD Anderson Cancer Center, University of Texas Houston, Texas, United States
View Trial Details
Completed

An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha

NCT00171223

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +20 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • H. Lee Moffet Cancer Center & Research Institute/Univ of South Florida Tampa, Florida, United States
  • Northwestern Univ meical School/Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
View all 28 locations
View Trial Details

Related conditions